欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/3464/001
药品名称Deirate
活性成分
    • dalbavancin 500.0 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Adalvo Limited Malta Life Sciences Park Building 1 Level 4 Sir Temi Zammit Buildings San Gwann Industrial Estate SGN 3000 Malta
参考成员国 - 产品名称Denmark (DK)
Deirate
互认成员国 - 产品名称
    • Cyprus (CY)
      Deirate 500 mg powder for concentrate for solution for infusion
    • Malta (MT)
许可日期2024/05/29
最近更新日期2024/05/31
药物ATC编码
    • J01XA04 dalbavancin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase